Jacobs Levy Equity Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-15,235
| Closed | -$4.96M | – | 1119 |
|
|
2021
Q3 | $4.96M | Buy |
15,235
+11,650
| +325% | +$3.79M | 0.03% | 432 |
|
|
2021
Q2 | $1.12M | Sell |
3,585
-912
| -20% | -$285K | 0.01% | 721 |
|
|
2021
Q1 | $1.43M | Sell |
4,497
-4,889
| -52% | -$1.56M | 0.01% | 660 |
|
|
2020
Q4 | $3.04M | Sell |
9,386
-45,506
| -83% | -$14.8M | 0.03% | 491 |
|
|
2020
Q3 | $15.2M | Sell |
54,892
-17,589
| -24% | -$4.87M | 0.16% | 148 |
|
|
2020
Q2 | $17.5M | Buy |
+72,481
| New | +$17.5M | 0.19% | 135 |
|
|
2020
Q1 | – | Sell |
-27,569
| Closed | -$4.7M | – | 1125 |
|
|
2019
Q4 | $4.7M | Buy |
+27,569
| New | +$4.7M | 0.05% | 386 |
|
|
2018
Q4 | – | Sell |
-658
| Closed | -$296K | – | 1098 |
|
|
2018
Q3 | $296K | Sell |
658
-11,523
| -95% | -$5.18M | ﹤0.01% | 868 |
|
|
2018
Q2 | $4.98M | Sell |
12,181
-13,192
| -52% | -$5.4M | 0.08% | 306 |
|
|
2018
Q1 | $7.38M | Sell |
25,373
-7,218
| -22% | -$2.1M | 0.12% | 218 |
|
|
2017
Q4 | $6.11M | Buy |
32,591
+11,893
| +57% | +$2.23M | 0.11% | 242 |
|
|
2017
Q3 | $3.49M | Sell |
20,698
-9,190
| -31% | -$1.55M | 0.07% | 314 |
|
|
2017
Q2 | $4.28M | Buy |
29,888
+550
| +2% | +$78.8K | 0.09% | 262 |
|
|
2017
Q1 | $3.67M | Buy |
29,338
+16,068
| +121% | +$2.01M | 0.07% | 308 |
|
|
2016
Q4 | $1.5M | Buy |
13,270
+2,250
| +20% | +$253K | 0.03% | 469 |
|
|
2016
Q3 | $1.42M | Buy |
+11,020
| New | +$1.42M | 0.03% | 495 |
|